Published in Springerplus on October 12, 2016
Virchow and his triad: a question of attribution. Br J Haematol (2008) 3.43
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.93
Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med (2004) 2.42
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol (1997) 2.41
Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost (2011) 2.14
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12
Pulmonary hypertension in COPD. Eur Respir J (2008) 2.03
The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med (2008) 2.02
Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med (2006) 1.96
Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med (2011) 1.89
Venous thromboemboli and exacerbations of COPD. Eur Respir J (2009) 1.87
Pulmonary hypertension in interstitial lung disease. Eur Respir J (2008) 1.53
Current understanding of disseminated intravascular coagulation. Br J Haematol (2004) 1.38
Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax (1988) 1.36
Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med (2002) 1.27
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest (1988) 1.17
Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost (2009) 1.17
Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. Am J Respir Crit Care Med (2010) 1.14
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J (2011) 1.07
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol (1999) 1.05
Introduction: health of the health care system in Korea. Soc Work Public Health (2010) 1.04
Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol (2006) 1.04
Disseminated intravascular coagulation in infectious disease. Semin Thromb Hemost (2010) 1.02
Longitudinal distribution of vascular resistance in the pulmonary arteries, capillaries, and veins. J Clin Invest (1968) 1.00
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis (2012) 0.94
Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax (2006) 0.93
Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII? Thromb Haemost (2005) 0.92
Pulmonary physiology during pulmonary embolism. Chest (1992) 0.90
Special issue on the national health care system of South Korea. Soc Work Public Health (2010) 0.84
Incidence of pulmonary embolism among hospitalized patients. Thromb Res (2011) 0.77